Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

You are browsing as a GUEST
Title of the item:

Listeria monocytogenes: A promising vehicle for neonatal vaccination

Title :
Listeria monocytogenes: A promising vehicle for neonatal vaccination
Authors :
Liang, Zach Z
Sherrid, Ashley M
Wallecha, Anu
Kollmann, Tobias R
Show more
Subject Terms :
Review
Publisher :
Taylor & Francis, 2014.
Publication Year :
2014
Original Identifier :
pmc: PMC4896561
pmid: 24513715
Language :
English
DOI :
10.4161/hv.27999
Vaccination as a medical intervention has proven capable of greatly reducing the suffering from childhood infectious disease. However, newborns and infants in particular are age groups for whom adequate vaccine-mediated protection is still largely lacking. With the challenges that the neonatal immune system faces and the required highest level of stringency for safety, designing vaccines for early life in general and the newborn in particular poses great difficulty. Nevertheless, recent advances in our understanding of neonatal immunity and its responses to vaccines and adjuvants suggest that neonatal vaccination is a task fully within reach. Among the most promising developments in neonatal vaccination is the use of Listeria monocytogenes (Lm) as a delivery platform. In this review, we will outline key properties of Lm that make it such an ideal neonatal and early life vaccine vehicle, and also discuss potential constraints of Lm as a vaccine delivery platform.

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.